STACEY RYDZEWSKA: Open Payments
NPI 1437778677 · FARMINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,902 in 88 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $98 · 2025 $1,902
Food & beverage: $1,902
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $353 |
| Madrigal Pharmaceuticals | 6 | $266 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $253 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $213 |
| Janssen Biotech, Inc. | 7 | $158 |
| Ardelyx, Inc. | 6 | $136 |
| Aimmune Therapeutics, Inc. | 5 | $134 |
| Phathom Pharmaceuticals, Inc. | 9 | $107 |
| Celltrion USA Inc. | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
Products named: REZDIFFRA, XIFAXAN, LINZESS, TREMFYA, IBSRELA, ZENPEP, RINVOQ, ENTYVIO.
Industry payments across CT — which companies pay providers there.
